Becton Dickinson - 15 Year Stock Price History | BDX
Historical daily share price chart and data for Becton Dickinson since 2011 adjusted for splits and dividends. The latest closing stock price for Becton Dickinson as of September 16, 2026 is 181.85.
- The all-time high Becton Dickinson stock closing price was 208.92 on July 27, 2023.
- The Becton Dickinson 52-week high stock price is 193.07, which is 6.2% above the current share price.
- The Becton Dickinson 52-week low stock price is 127.59, which is 29.8% below the current share price.
- The average Becton Dickinson stock price for the last 52 weeks is 158.10.
| Becton Dickinson Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2026 | 159.9421 | 150.3300 | 190.8740 | 139.8850 | 181.8500 | 21.51% |
| 2025 | 150.3520 | 170.9610 | 188.0130 | 125.2270 | 149.6590 | -12.61% |
| 2024 | 175.6744 | 182.1590 | 184.4090 | 165.2920 | 171.2480 | -5.38% |
| 2023 | 186.8424 | 187.3170 | 208.9180 | 168.6150 | 180.9790 | -2.67% |
| 2022 | 180.6508 | 178.1670 | 199.2930 | 159.0230 | 185.9420 | 5.08% |
| 2021 | 173.3683 | 174.0160 | 184.3180 | 165.3520 | 176.9490 | 1.88% |
| 2020 | 170.6371 | 186.6540 | 195.8650 | 137.8260 | 173.6830 | -6.75% |
| 2019 | 168.2750 | 148.8770 | 187.3040 | 142.8700 | 186.2630 | 22.20% |
| 2018 | 158.4253 | 145.4890 | 178.2730 | 141.1370 | 152.4210 | 6.61% |
| 2017 | 129.1550 | 108.6690 | 151.8930 | 108.4390 | 142.9650 | 31.24% |
| 2016 | 106.8825 | 95.7584 | 118.9310 | 86.0046 | 108.9320 | 9.22% |
| 2015 | 92.2929 | 88.9946 | 101.3120 | 84.0368 | 99.7324 | 12.63% |
| 2014 | 75.1907 | 68.1882 | 89.4978 | 65.8515 | 88.5492 | 28.27% |
| 2013 | 60.5884 | 48.6195 | 69.1004 | 48.6195 | 69.0316 | 44.27% |
| 2012 | 46.0979 | 44.4565 | 48.4236 | 43.3597 | 47.8485 | 7.24% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $51.228B | $21.840B |
| Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $104.880B | 22.04 |
| Cardinal Health (CAH) | United States | $54.109B | 20.66 |
| West Pharmaceutical Services (WST) | United States | $25.687B | 42.94 |
| Straumann Holding AG (SAUHY) | Switzerland | $18.592B | 0.00 |
| Align Technology (ALGN) | United States | $10.528B | 16.28 |
| Cooper (COO) | United States | $10.130B | 11.56 |
| Henry Schein (HSIC) | United States | $9.754B | 16.48 |
| Merit Medical Systems (MMSI) | United States | $5.146B | 23.48 |
| DENTSPLY SIRONA (XRAY) | United States | $1.960B | 6.87 |
| CONMED (CNMD) | United States | $1.406B | 9.82 |
| STAAR Surgical (STAA) | United States | $1.125B | 35.07 |
| Pro-Dex (PDEX) | United States | $0.214B | 19.97 |
| Lifevantage (LFVN) | United States | $0.077B | 11.04 |